However, response may vary: Higher baseline weight Individuals starting at higher body weights may experience: Slower percentage weight loss initially Need for full maintenance doses to achieve optimal effects Potentially better tolerance of higher doses Lower baseline weight Those with lower starting weights might: Achieve therapeutic goals at submaximal doses (e.g., 2.4 mg vs
Sheu T, Vock DM, Mohamed AS, Gross N, Mulcahy C, Zafereo ME , Gunn GB, Garden AS, Sevak P, Phan J, Lewin JS, Frank SJ, Beadle BM, Morrison WH, Lai SY, Hutcheson K, Marai GE, Canahuate GM, Kies M, El-Naggar A, Weber RS, Rosenthal DI, Fuller CD
ubiquitin-like proteins that function in cargo recruitment to autophagosomes and autophagosomelysosome fusion
This content is available through your Curated Research partnership with Advisory Board
The framing that matters is systemic versus targeted, not stronger versus weaker
Nayan Patel: I have